Linda Yaccarino, less than a month after stepping down as CEO of Elon Musk's X, has found her next gig. Yaccarino has been named CEO of Miami-based eMed Population Health, which calls itself "the leading digital health platform for GLP-1/GIP population health management." That refers to the class of weight-loss drugs like Wegovy and Ozempic. [...]
Variety
Mild Linda Yaccarino, After Exiting Elon Musk's X, Tapped as CEO of Weight-Loss Drug Management Company eMed
August 5, 2025
4 months ago
1 celebrity mentioned
Original Source:
Read on Variety
Health Analysis Summary
Our AI analysis has identified this article as health-related content with a severity level of 4/10.
This analysis is based on keywords, context, and content patterns related to medical news, health updates, and wellness information.
Celebrities Mentioned
Share this article: